ReviewBiomimetics (Basel, Switzerland)2026
Advances in 3D Printed Bone Implants: Smart Responsive Antibacterial Strategies and AI-Driven Design.
Review in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
For critical-sized bone defects, bioactive implants are indispensable. Although advanced three-dimensional (3D) printing technology enables the precise manufacturing of customized bone scaffolds, implant-associated infections (IAIs) remain a significant clinical challenge. Moreover, traditional passive antibacterial coatings often face problems such as uncontrolled release of antibacterial agents and insufficient long-term antibacterial efficacy. This review elaborates on the transformation of antibacterial strategies in the field of bone tissue engineering (BTE) from "passive" to "smart responsive" modes. We summarize the endogenous (such as pH, temperature, reactive oxygen species (ROS), and enzyme) and exogenous (such as light, microwave, and ultrasound) response systems. Notably, the ultrasound-driven strategy is highly emphasized due to its outstanding deep tissue penetrability and dual functional characteristics: it can not only eliminate stubborn biofilms through the sonodynamic effect by generating ROS, but also promote osteogenesis through the piezoelectric effect. Additionally, we also discuss the recent progress of artificial intelligence (AI) in the field of bone scaffold manufacturing. AI-driven algorithms help to rapidly optimize complex scaffold structures and accurately predict their mechanical properties, thereby effectively avoiding the inefficiencies brought about by the traditional "trial and error" method. In conclusion, combining AI-assisted manufacturing technology with smart responsive antibacterial strategies opens up a highly promising frontier field for the development of personalized and infection-free bone implants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.